CNS Pharmaceuticals, Inc.
Institutional Ownership & Holdings Analysis
About
cns-pharmaceuticals is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | UBS Group AG(2025-03-31) | $32.6K |
| 2 | Ground Swell Capital, LLC(2025-03-31) | $15.4K |
| 3 | Tower Research Capital LLC (TRC)(2025-03-31) | $7.0K |
| 4 | BARRETT & COMPANY, INC.(2025-03-31) | $136 |
| 5 | MAI Capital Management(2025-03-31) | $55 |
| 6 | SBI Securities Co., Ltd.(2025-03-31) | $20 |
| 7 | BANK OF AMERICA CORP /DE/(2025-03-31) | $12 |
| 8 | CONCOURSE FINANCIAL GROUP SECURITIES, INC.(2025-03-31) | $0 |
As of 2025-03-31
Value:$32.6K
As of 2025-03-31
Value:$15.4K
As of 2025-03-31
Value:$7.0K
As of 2025-03-31
Value:$136
As of 2025-03-31
Value:$55
As of 2025-03-31
Value:$20
As of 2025-03-31
Value:$12
As of 2025-03-31
Value:$0
Total Institutional Holders:8
Top 10 Holders Own:100.0%